Jonathan Goldman

AVTX

Jonathan Goldman serves as Director at Avalo Therapeutics, Inc. (AVTX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$162.9K

Net Position

Net Seller

$162.9K

Companies Traded

AVTX

Active Period

Nov 2025

1 total trades

Most Recent

Sell AVTX

Nov 14, 2025 · $162.9K

Jonathan Goldman's Insider Trading at Avalo Therapeutics, Inc. (AVTX)

Buys

0 · $0.00

Sells

1 · $162.9K

Total Shares Bought

Total Shares Sold

11,367

AVTX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 14, 2025	Sell	11,367	$14.33	$162.9K	0

Related Insiders

Mittie Doyle

officer: Chief Medical Officer

AVTXSell · Jun 1, 2026

Christopher Ryan Sullivan

officer: Chief Financial Officer

AVTXSell · May 11, 2026

Mitchell Chan

director

AVTXSell · May 7, 2026

VARKI PAUL

officer: Chief Legal Officer

AVTXSell · May 7, 2026

Jennifer Riley

Chief Strategy Officer

AVTXSell · Dec 10, 2025

Explore More Insider Trading Data

AVTX Insider Trading Activity

View all insider trades at Avalo Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity